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Abstract
Background: HIV-related stigma is a barrier to effective HIV responses among people living with HIV (PLHIV).
Objectives: The current study aimed at measuring HIV-related stigma, and its associated factors among the general population in
the Southeast of Iran.
Methods: The current cross-sectional study was conducted on a convenience sample of 900 individuals in Kerman, Southeast of
Iran, from July to September 2016. Data was collected using a self-administered questionnaire, including (I) demographic and back-
ground characteristics; (II) HIV-related stigma; and (III) HIV-related knowledge. Data were analyzed with SPSS version 20 using de-
scriptive statistics, as well as bivariable and multivariable linear regressions.
Results: Low, moderate, and high levels of stigmatizing attitudes toward PLHIV were reported by 39.1%, 57.8%, and 3.1% of the partic-
ipants, respectively. Female sex(beta = 0.33, P value = 0.01) and those not having a history of HIV testing (beta = 0.45, P value < 0.001)
had, on average, higher levels of stigmatizing attitudes, while those with a higher level of education (beta = -0.97, P value < 0.001)
had, on average, lower levels of stigmatizing attitudes.
Conclusions: Gender-sensitive educational interventions need to be developed to reduce the negative attitude towards PLHIV in
Iran.
Keywords: Stigma, Attitude, Knowledge, People Living with HIV, Iran
1. Background
HIV-related stigma is considered one of the main ob-
stacles to an effective response to the HIV epidemic world-
wide (1). The Joint United Nations program on HIV/AIDS
(UNAIDS) defines HIV related stigma as “a process of deval-
uation of people either living with or associated with HIV
and AIDS” (2). Stigma could be manifested in two ways: (1)
internal stigma, which leads to an unwillingness to seek
help and access resources; and (2) external stigma, which
leads to discrimination by HIV status or association with
someone living with HIV/AIDS (3). Stigma and discrimina-
tion affect preventive measures of HIV transmission (4-7),
and reduce PLHIV’s access to health services, social interac-
tions, and supports (5, 8, 9); issues more pronounced in the
context of conservative and Islamic countries (10).
In Iran, with the highest number of known PLHIV in
the Middle East (i.e., 35,000), the HIV epidemic is mainly
concentrated on people who inject drugs and female sex
workers; however, a shift in the primary mode of trans-
mission from drug use to sexual behaviors is evident (11-
15). Although the onset of the epidemic in Iran was
33 years ago (1987), PLHIV continue to experience signif-
icant HIV-related stigma and are often shunned by the
general public. While there is a growing literature on
HIV-related stigma worldwide, the understanding of HIV-
related stigma among the general population in Iran re-
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mains very limited (16, 17) and most studies focus on knowl-
edge and attitudes of the general population towards HIV
(18-22).
Previous stigma studies mainly investigated the lived
experiences of PLHIV and highlighted the high levels of
internal and external stigma among them in a variety of
contexts. For example, participants mentioned internal
stigma such as silence, shame, and feeling miserable; they
also reported experiencing external stigma by their fami-
lies, the community, and the health-care system (3, 23-27).
2. Objectives
Due to the limited understanding of HIV-related
stigma among the general population and the limitations
of the existing narrow body of evidence in Iran (e.g., small
sample size, qualitative study designs), the present study
aimed at assessing HIV-related stigma among the general
population in the Southeast of Iran in 2016.
3. Methods
3.1. Participants and Setting
The current cross-sectional study was conducted in
Kerman (the largest city in the Southeast of Iran with a pop-
ulation of about 750,000 inhabitants) from July to Septem-
ber 2016. Since it was assumed that 50% of the general pop-
ulation had stigmatizing attitudes (28), with a 95% confi-
dence interval and the precision level of 0.07, the sample
size of 784 was calculated. Due to the convenience nature
of the sample, the questionnaires were distributed among
1045 individuals that 900 of them answered the items (re-
sponse rate = 86.1%).
Kerman City consists of four urban regions. There-
fore, first, the city was divided into four strata. Within
each stratum, neighborhoods were considered as clusters,
and some neighborhoods were randomly selected. In each
cluster, according to the sample size, trained interview-
ers selected participants from different crowded streets
and public places (e.g., shopping centers, parks, transit sta-
tions) at different times of the day. According to the re-
sults of previous studies in Iran, people are more likely to
disclose sensitive information (e.g., sexual health-related
topics) in street-based surveys compared with household-
or telephone-based surveys (29, 30). Individuals above 18
years old and being able to make verbal communication
were eligible to be included in the study. People who had
not heard anything about HIV were excluded from the
study. The questionnaire was self-administered; however,
in case of insufficient literacy, the questionnaire was com-
pleted with the interviewer’s assistance.
3.2. Ethical Considerations
The study protocol was reviewed and approved by the
Ethics Committee of the Kerman University of Medical Sci-
ences (ethical code: IR.KMU.REC.1395.140). Before starting
the interview, the participants were provided with infor-
mation about the objectives of the study; they were also
assured of the confidentiality of their information and the
anonymity of the data. The participants provided verbal in-
formed consent and could withdraw from the interview at
any time.
3.3. Data Collection
Data collection was completed using a three-part
researcher-made questionnaire, including (I) demo-
graphic and background characteristics; (II) HIV-related
stigma; and (III) HIV-related knowledge. The question-
naire collected information on age (< 30 or ≥ 30 years),
sex (male or female), marital status (never married or sin-
gle or ever married), education level (below high school
diploma, diploma, or college/university degree), current
occupational status (unemployed/housewife, university
student, or employed), self-reported knowledge of high-
risk behaviors (yes or no), and a history of such behaviors
(yes or no), knowledge of HIV (continuous), sources of
receiving information about HIV (scientific books, mass
media, internet/social networks, family/friends/relatives,
healthcare centers, or school/university), the history of
HIV testing (yes or no), and the history of history of pre-
vious interactions with an individual living with HIV if
they knew any (yes or no). Knowledge of HIV transmission
was measured using a scale with three items with the fol-
lowing response options: correct, incorrect, and I do not
know. The sum of the scores yielded a final score ranging
from 0 to 24 and then standardized based on a value from
0 to 20, with higher scores indicating higher knowledge
of HIV. Then the standardized scores were categorized as
poor (< 10), moderate (10 - 14), and high knowledge (> 14)
(21).
HIV-related stigma was measured using the HIV-
related stigma index, an 18-item scale with four subscales.
The subscales were the patient’s social position with five
items, social support with four items, social disease per-
spective with seven items, and social harassment with
two items (Table 1). Items were scored based on a five-
point Likert scale ranging from completely agree (score
5) to completely disagree (score 1), yielding an overall
score ranged from 18 to 90, with a higher score indicat-
ing a higher level of HIV-related stigma (i.e., negative
perception) towards PLHIV. The psychometric properties
of the questionnaire were evaluated using content and
2 Shiraz E-Med J. 2020; 21(7):e96311.
DehghanM et al.
construct validity, and internal consistency and repeata-
bility. To measure the validity of the questionnaire, the
comments of 15 experts (i.e., nurses, midwives, social
medicals, health education specialists, sociologists, and
epidemiologists) were used. The content validity index
was 0.98. The construct validity showed that the index had
four dimensions: the patient’s social position (five items),
social support (four items), social disease perspective
(seven items), and social harassment (two items). The con-
firmatory factor analysis showed that the four-dimension
index of stigma had suitable fit indices. In addition, the
scale had a good internal consistency and stability (Cron-
bach’s alpha coefficient = 0.69 and intraclass correlation
coefficient = 0.57).
For the analysis, the scores were standardized based on
a value from 0 to 20, higher scores indicating higher HIV-
related stigma. Then the standardized scores were catego-
rized as poor (< 6), moderate (6 - 10), and high stigma (>
10).
3.4. Data Analysis
Descriptive statistics were reported for continuous
(mean and standard deviation (SD) and categorical (abso-
lute and relative frequencies) measures. To examine the
factors associated with HIV-related stigma, first, multiple
bivariable linear regression models were run in which HIV-
related stigma was the dependent variable of the study,
and demographic, background, and HIV knowledge were
considered as independent factors. To deal with the issue
of bias due to confounding, multivariable linear regres-
sion was also performed. A three-stage model-building ap-
proach was used to assess the effect of different variables
on the stigma score. In the first stage, the correlation anal-
ysis of independent variables was conducted to identify
pairs of variables that essentially contained the same in-
formation and had to be removed due to collinearity. In
the second stage, the bivariable analysis was performed
to identify variables associated with stigma. During this
screening phase, a significance level of 0.25 was used. In
the third stage, all variables with P < 0.25 were simultane-
ously inserted into a full model subsequently reduced by
backward elimination. The procedure was repeated until
all the remaining variables were significant at P < 0.05 (31).
Data were analyzed using SPSS version 20.
4. Results
4.1. Participants Characteristics
Totally, 900 males and females above 18 years old re-
sponded to the items in the questionnaire (response rate =




Disagree No Idea Agree
Dimension I: The patient’s social
position
The person living with HIV
should be ashamed of
his/her disease.
86 (12.3) 91 (13.0) 523 (74.7)
The family of PLHIV should
be ashamed of having such
a family member.
281 (40.1) 189 (27.0) 230 (32.9)
In our society, PLHIV are
rejected and forgotten by
their families.
227 (32.5) 198 (28.4) 288 (42.0)
In our society, PLHIV are
rejected and forgotten by
their close friends.
176(25.1) 165 (23.6) 359 (51.3)
PLHIV will lose their respect
and social status.
173 (24.7) 143 (20.5) 383 (54.8)
Dimension II: Social support
Physicians, nurses, and
other care providers should
treat PLHIV like other
patients.
52 (7.4) 123 (17.6) 525 (75.0)
PLHIV should be welcomed
in social participation.
46 (6.7) 87 (12.4) 566 (80.9)
PLHIV should be allowed to
work and cooperate with
others.
23 (3.3) 77 (11.0) 599 (75.7)
PLHIV should be treated like
anyone else in the society.
227 (32.5) 193 (28.4) 288 (42.0)
Dimension III: Social disease
perspective
All PLHIV are guilty. 10 (1.4) 59 (8.5) 629 (90.1)
PLHIV are disgusting. 560 (80.3) 123 (17.6) 15 (2.1)
Only those who involve in
high-risk sexual
relationships are at risk of
HIV.
466 (66.9) 181 (26.0) 49 (7.1)
PLHIV should be punished. 530 (76.0) 151 (21.6) 16 (2.4)
HIV is a punishment of an
individual’s behavior in the
past.
408(58.5) 227 (32.6) 62 (8.9)
Quarantine of PLHIV is the
best method to control HIV.
413 (59.0) 216 (30.9) 71 (10.1)
We should not buy fruits
and vegetables from PLHIV.
395 (56.7) 264 (37.9) 38 (5.4)
Dimension IV: Social harassment
In our society, PLHIV are
verbally assaulted.
159 (22.7) 169 (24.1) 372 (53.2)
PLHIV are physically
assaulted in our society.
327 (46.7) 212 (30.3) 160 (23.0)
aValues are expressed as N (%).
86.1%). Of the overall sample analyzed (n = 900), the mean
± SD age of participants was 35.89 ± 12 years, 50% were
male, 33.8% were single, 57% reported having a university
degree, and 63.6% had a job (Table 2).
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Table 2. Demographic and Background Characteristics of Participants to Estimate
the HIV Knowledge and Stigma in the Southeast of Iran
Variable N (%)
Age, y
< 30 316 (35.4)






Ever married 596 (66.2)
Educational Level





University student 141 (15.7)
Employed 573 (63.6)
Knowing of high-risk behaviors, yes 668 (74.3)
History of being involved in high-risk behaviors, yes 132 (14.7)
Ever tested for HIV 152 (16.9)
Last HIV testing
Within last year 35 (23.0)
Within 1-2 years ago 34 (22.4)
Before 2 years ago 83 (54.6)
Self-reported sufficient knowledge of HIV, yes 802 (89.8)
Sources of information about HIVa
Scientific books 186 (22.2)
Mass media (radio, television, …) 720 (86.1)
Internet and social networks 404 (48.3)
Family/friends/relatives 236 (28.2)
Healthcare centers 167 (20)
School/university 355 (42.5)
Knowing an individual living with HIV, yes 84 (9.4)






Low (positive perception) 352 (39.1)
Moderate 520 (57.8)
High (negative perception) 28 (3.1)
aParticipants could select more than one choice.
Overall, 74.3% of the participants believed that they
were aware of the high-risk behaviors, 14.7% reported in-
volvement in at least one high-risk behavior, and 16.9% re-
ported a history of HIV testing. A significant proportion
of the participants (89.8%) assumed they knew about HIV
and mass media (radio, television, newspapers, and mag-
azines) was reported as the main source of HIV-related
information (86.1%). While knowing an individual liv-
ing with HIV was reported by 9.4%, only 3.9% had regu-
lar communication with such individuals. The mean ±
SD score of HIV-related knowledge was 16.05 ± 2.27 (on a
scale ranging from 0 to 20). The high, moderate, and low
HIV-related knowledge levels were respectively estimated
among 87.6%, 11.7%, and 0.8% of the participants (Table 2).
The mean (± SD) score of HIV-related stigma was 7.5
(± 1.94), ranging from 1.11 to 14.72 out of a possible range
of 0 to 20. Of the total sample, 39.1% had a low level,
57.8% moderate level, and only 3.1% had a high level of
HIV-related stigma towards PLHIV. According to the re-
sults of dimension I (patient’s social position), about 75%
of the participants agreed/completely agreed that “PLHIV
should be ashamed of their disease”. Also, 55% of them
agreed/completely agreed that “PLHIV will lose their re-
spect and social status”. According to the results of di-
mension III (social disease perspective), 90% of the partici-
pants agreed/completely agreed that “all PLHIV are guilty”.
Based on dimension IV (social harassment), 53% of them
agreed/completely agreed that “In Iran, PLHIV is verbally
assaulted” (Table 1).
In addition, the scores of each dimension were calcu-
lated based on a value from 0 to 20. The means (± SD) of
patient’s social position, social support, social disease per-
spective, and social harassment were 12.02 (± 4.38) rang-
ing: 0 - 20, 4.12 (± 2.95) ranging: 0 - 16.25, 12.02 (± 4.38)
ranging: 0 - 20, and 4.59 (± 10.23) ranging: 0 - 20, respec-
tively. Therefore, the lowest level of stigma belonged to the
social support dimension, followed by social harassment.
4.2. Factors Associated with HIV-Related Stigma
Results of the bivariable linear regression showed that
higher HIV knowledge, higher education level, and being a
university student were associated with lower levels of HIV-
related stigma (i.e., more positive perception), while being
female, lack of knowledge of high-risk behaviors, and no
history of HIV testing were associated with higher levels of
HIV-related stigma (i.e., more negative perception). Anal-
ysis of the multivariable linear regression demonstrated
that individuals with higher levels of HIV knowledge (beta
= -0.05, P-value = 0.05), having a high school diploma (beta
= -0.64, P-value = 0.006) or higher education (beta = -0.97,
P-value < 0.001) had, on average, significantly a lower level
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of HIV-related stigma. Conversely, females (beta = 0.33,
P-value = 0.01) and those never having HIV testing (beta
= 0.45, P-value = 0.009) had, on average, significantly a
higher level of HIV-related stigma (Table 3).
5. Discussion
In the current study, a high proportion of either mod-
erate (57.8%) or high (3.1%) level of HIV-related stigma was
documented in the study population, indicating negative
perceptions or attitudes towards PLHIV. Interestingly, it
was found that females had more negative perceptions.
In addition, higher stigma was associated with not having
had an HIV test, while higher HIV knowledge and a higher
level of education were associated with lower HIV-related
stigma. Consistent with the current study results, other
research also reported a high level of HIV-related stigma.
For example, a study on stigma against PLHIV among mi-
grant females living in Shanghai, China, reported that 80%
of the participants were afraid of PLHIV and above half of
them had a discriminative attitude towards them (32). In a
nationwide study in Iran among young individuals (2016)
it was reported that only 20.7% had positive attitudes to-
wards PLHIV (21).
Although previous studies showed a relatively high
level of stigma in Iran and it was repeatedly reported that
PLHIV experienced stigmatizing practices (3, 17, 23), the cur-
rent study findings suggested a shift in individuals’ atti-
tude toward PLHIV in the past few years probably due to
the role of media; nonetheless, moderate levels of stigma
were frequent. To support the pivotal role of national me-
dia, it was observed that more than 80% of the study partic-
ipants reported that mass media (radio, television, news-
paper, and magazines) was the main source of receiving re-
liable information about HIV. A national population-based
survey among Iranian youth selected by convenience sam-
pling reported that almost 70% of the participants ob-
tained their information about HIV from mass media (21).
Despite the key role of such mass media-based ap-
proaches to improve the knowledge of the general pop-
ulation of HIV, and its effect on HIV testing referrals (33),
such a high level of stigma within the general popula-
tion implicated that although the current interventions
appeared to be beneficial, they require improvement to ef-
fectively reduce the negative attitudes towards PLHIV in
Iran. In line with prior studies in Shanghai, China, Vi-
entiane, and Heilongjiang, Northeast China (32, 34, 35),
the current study also found a significant inverse associ-
ation between higher levels of HIV knowledge and lower
levels of HIV-related stigma. Therefore, public education
campaigns aimed at improving knowledge and reducing
HIV-related stigma in the general population. Such ap-
proaches should also enhance communications among pa-
tients with HIV and the general population; for example,
providing training programs for the general population to
increase their awareness in the national AIDS day and other
related events. The interventions in which individuals
with HIV are involved may reduce the level of HIV-related
stigma among the general population; an approach called
the contact hypothesis (36) through which prejudice or
discriminatory attitudes towards other groups, here peo-
ple with HIV, can be mitigated via intergroup interactions
(37).
Development of the stigma-reduction interventions
is particularly imperative among females since the cur-
rent study found that females had a higher level of HIV-
related stigma. Females in Iran historically experience
greater social, cultural, and contextual barriers (24, 38)
that might impact their knowledge level and attitudes. The
current study findings may indicate gender-based inter-
ventions in which females’ negative attitudes toward HIV
can be effectively addressed. It is required that the gov-
ernment and policymakers make more attempts to scale
up and implement stigma-reduction strategies such as HIV
education and prevention campaigns at the community
level, in which cultural and social norms are taken into
account (39). Apart from the community-based interven-
tions, other studies proposed a combination of multiple
strategies at different levels of individual, interpersonal,
organizational, and public policy to address the issue of
HIV-related stigma and discrimination better (7).
It was also identified that around one-sixth of the par-
ticipants reported the history of HIV testing. Subsequently,
it was found that individuals reporting HIV testing had
a greater level of positive attitudes towards HIV and PL-
HIV compared with the ones that never did HIV testing.
The current study did not explore the reasons for HIV test-
ing among the participants; however, this proportion was
consistent with prior studies in Iran (13.6%) (40) and other
countries (13.1%) (21). Therefore, stigma reduction strate-
gies may require addressing the importance of HIV testing.
While previous studies predominantly focused on the im-
pact of HIV-related stigma on the reduction of individuals’
desire to involve in HIV testing (41), the current study iden-
tified the-other-way-round association. Although such re-
verse association might be due to the nature of the sam-
pling strategies of the study, this may not impact the im-
portance of both HIV testing and HIV-related stigma and
their associations.
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Table 3. Correlates of HIV-Related Stigma Among the General Population in the Southeastern of Iran
Variable
Bivariable Liner Regression Multivariable Liner Regression
Beta 95% CIa P Value Beta 95% CI P Value
HIV-related knowledge -0.07 -0.13, -0.02 0.01 -0.05 -0.10, 0.01 0.050
Age, y
< 30 Ref.
≥ 30 0.26 -0.01, 0.52 0.06
Sex
Male Ref. Ref.
Female 0.34 0.08, 0.59 0.009 0.33 0.08, 0.58 0.010
Marital status
Single Ref
Married/divorced/widow -0.17 -0.44, 0.09 0.19
Education level
Below high school diploma Ref Ref.
Diploma -0.72 -1.19, -0.26 0.002 -0.64 -1.10, -0.19 0.006
College/university -1.1 -1.53, -0.65 < 0.001 -0.97 -1.40, -0.53 < 0.001
Occupation
Unemployed/housewife Ref
University student -0.55 -0.98, -0.13 0.01
Employed -0.24 -0.56, 0.08 0.15
Knowledge of high-risk behaviors
Enough Ref.
Not enough 0.45 0.16, 0.74 0.002
Reported involvement in high-risk
behaviors
No Ref.
Yes 0.14 -0.23, 0.52 0.44
History of HIV testing
Yes Ref. Ref.
No 0.6 0.26, 0.94 0.001 0.45 0.11, 0.78 0.009
aConfidence interval.
5.1. Study Limitations
Authors acknowledge the limitations of the study. The
first limitation was that the study was conducted only in
Kerman, and the results cannot be generalized to the en-
tire country. However, the authors believe that the study
findings in a large urban setting are informative for other
provinces of the country. The second limitation was that
the study relied on self-reported attitudes and it is there-
fore subject to reporting bias. Overall, given the scope of
the study, the authors believe that the findings have impor-
tant implications for both research and policy.
5.2. Conclusions
Approximately 60% of the study participants reported
experiencing a moderate-to-high level of HIV-related
stigma towards PLHIV. Gender-based stigma-reduction
strategies and increasing HIV-related knowledge have the
potential to reduce negative attitudes toward HIV. While
mass media-based strategies can still be considered as
one of the main strategies, multiple approaches in which
different levels of individual, organizational, and com-
munities are considered can better address HIV-related
stigma. Educational and preventive national campaigns
in which a broad range of population is covered can
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be considered as an important strategy to reduce HIV
discrimination and stigma.
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